Cargando…
Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case–control study
BACKGROUND: Patients with myocardial infarction (MI) have a high mortality. Therefore, new risk markers and predictors of an adverse outcome for MI are required. The role of hyperglycemia in the development of cardiovascular complications in MI patients is still unclear. METHODS: A total of 529 cons...
Autores principales: | Karetnikova, Victoria, Gruzdeva, Olga, Uchasova, Evgenya, Osokina, Anastasia, Barbarash, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888504/ https://www.ncbi.nlm.nih.gov/pubmed/27246347 http://dx.doi.org/10.1186/s12902-016-0108-8 |
Ejemplares similares
-
Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
por: Karetnikova, Victoria, et al.
Publicado: (2016) -
Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016) -
Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction
por: Karetnikova, Victoria, et al.
Publicado: (2017) -
Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
por: Belenkova, Yulia, et al.
Publicado: (2015) -
Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
por: Gruzdeva, Olga, et al.
Publicado: (2016)